These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2959472)

  • 1. Comparative in vitro activity of the new macrolide A-56268 against mycobacteria.
    Berlin OG; Young LS; Floyd-Reising SA; Bruckner DA
    Eur J Clin Microbiol; 1987 Aug; 6(4):486-7. PubMed ID: 2959472
    [No Abstract]   [Full Text] [Related]  

  • 2. Nifurtimox Is Ineffective against Drug-Resistant Mycobacteria.
    Ruth MM; Sangen JJN; Wertheim HFL; van Ingen J
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652235
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
    Thomas L; Naumann P; Crea A
    Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-lactam antibiotics and mycobacteria.
    Finch R
    J Antimicrob Chemother; 1986 Jul; 18(1):6-8. PubMed ID: 3093446
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
    Davies S; Sparham PD; Spencer RC
    J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
    Casal M; Gutierrez J; Ruiz P; Moreno G
    Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex.
    Steadham JE; Stall SK; Simmank JL
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):33-40. PubMed ID: 3917885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising new drugs in the treatment of tuberculosis and mycobacteriosis.
    Casal M; Rodríguez F; Gutierrez J; Ruiz P; Benavente MC; Villalba R; Moreno G
    J Chemother; 1989 Feb; 1(1):39-45. PubMed ID: 2498468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antimycobacterial S-alkylisothiosemicarbazones.
    Waisser K; Heinisch L; Slosárek M; Janota J
    Folia Microbiol (Praha); 2005; 50(6):479-81. PubMed ID: 16681143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of quinolones and macrolides against mycobacteria.
    Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
    J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
    Texier-Maugein J; Mormède M; Fourche J; Bébéar C
    Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
    Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
    Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods.
    Trimble KA; Clark RB; Sanders WE; Frankel JW; Cacciatore R; Valdez H
    J Antimicrob Chemother; 1987 May; 19(5):617-22. PubMed ID: 3112096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.
    Rastogi N; Goh KS; David HL
    Ann Inst Pasteur Microbiol; 1988; 139(2):233-7. PubMed ID: 3165641
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.
    Fenlon CH; Cynamon MH
    Antimicrob Agents Chemother; 1986 Mar; 29(3):386-8. PubMed ID: 2940969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatis.
    Doucet-Populaire F; Capobianco JO; Zakula D; Jarlier V; Goldman RC
    J Antimicrob Chemother; 1998 Feb; 41(2):179-87. PubMed ID: 9533459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterial plasmids: screening and possible relationship to antibiotic resistance in Mycobacterium avium/Mycobacterium intracellulare.
    Franzblau SG; Takeda T; Nakamura M
    Microbiol Immunol; 1986; 30(9):903-7. PubMed ID: 3540539
    [No Abstract]   [Full Text] [Related]  

  • 19. [New active drugs against the tuberculosis bacillus and other mycobacteria].
    de Kantor IN
    Medicina (B Aires); 1986; 46(1):107-12. PubMed ID: 3100907
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteria.
    Tomioka H; Sato K; Saito H
    Tubercle; 1991 Sep; 72(3):176-80. PubMed ID: 1771676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.